Metagenomi
Andrew Farquharson is a seasoned leader in healthcare innovation, currently serving as Managing Director at InCube Ventures, LLC and VHM Ventures since September 2007 and January 2017, respectively. With a strong focus on breakthrough healthcare solutions aimed at enhancing clinical outcomes, Andrew also holds board positions at Rani Therapeutics, LLC, Metagenomi, and WhiteSwell, where efforts are directed towards improving treatment for acute decompensated heart failure. Prior experience includes roles as Senior Vice President at Operon Technologies, Inc. and Senior Lead Technician/Shift Manager at Genentech. Andrew's academic credentials include an MBA from Harvard Business School and a BA from the University of California, Berkeley.
This person is not in any teams